Robert N. Fried - Feb 17, 2022 Form 4 Insider Report for ChromaDex Corp. (CDXC)

Role
CEO, Director
Signature
/s/ Jeong James Lee, Attorney-in-Fact
Stock symbol
CDXC
Transactions as of
Feb 17, 2022
Transactions value $
$0
Form type
4
Date filed
2/22/2022, 04:28 PM
Previous filing
May 17, 2021
Next filing
Mar 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDXC Employee Stock Options (right to buy) Award $0 +240K $0.00 240K Feb 17, 2022 Common Stock 240K $2.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third of the shares subject to the option shall vest on February 17, 2023 and the remaining shares subject to the option shall vest in a series of 24 equal monthly installments thereafter.